BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36262770)

  • 1. European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease.
    Sannino A; Campbell S; Grapsa J; Modine T; Barbanti M; Chambers JB; Zamorano JL; Pibarot P; Garbi M; Vannan M; Habib G; Lancellotti P
    Eur Heart J Open; 2022 Sep; 2(5):oeac054. PubMed ID: 36262770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
    Iung B; Delgado V; Rosenhek R; Price S; Prendergast B; Wendler O; De Bonis M; Tribouilloy C; Evangelista A; Bogachev-Prokophiev A; Apor A; Ince H; Laroche C; Popescu BA; Piérard L; Haude M; Hindricks G; Ruschitzka F; Windecker S; Bax JJ; Maggioni A; Vahanian A;
    Circulation; 2019 Oct; 140(14):1156-1169. PubMed ID: 31510787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; de Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B
    Thromb Haemost; 2017 Dec; 117(12):2215-2236. PubMed ID: 29212110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease.
    Iung B; Baron G; Butchart EG; Delahaye F; Gohlke-Bärwolf C; Levang OW; Tornos P; Vanoverschelde JL; Vermeer F; Boersma E; Ravaud P; Vahanian A
    Eur Heart J; 2003 Jul; 24(13):1231-43. PubMed ID: 12831818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology.
    Chioncel O; Adamo M; Nikolaou M; Parissis J; Mebazaa A; Yilmaz MB; Hassager C; Moura B; Bauersachs J; Harjola VP; Antohi EL; Ben-Gal T; Collins SP; Iliescu VA; Abdelhamid M; Čelutkienė J; Adamopoulos S; Lund LH; Cicoira M; Masip J; Skouri H; Gustafsson F; Rakisheva A; Ahrens I; Mortara A; Janowska EA; Almaghraby A; Damman K; Miro O; Huber K; Ristic A; Hill L; Mullens W; Chieffo A; Bartunek J; Paolisso P; Bayes-Genis A; Anker SD; Price S; Filippatos G; Ruschitzka F; Seferovic P; Vidal-Perez R; Vahanian A; Metra M; McDonagh TA; Barbato E; Coats AJS; Rosano GMC
    Eur J Heart Fail; 2023 Jul; 25(7):1025-1048. PubMed ID: 37312239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution, Characteristics, and Management of Older Patients With Valvular Heart Disease in China: China-DVD Study.
    Xu H; Liu Q; Cao K; Ye Y; Zhang B; Li Z; Hao J; Qi X; Zhao Q; Liu S; Gao R; Wu Y;
    JACC Asia; 2022 Jun; 2(3):354-365. PubMed ID: 36338396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Computed Tomography: Application in Valvular Heart Disease.
    Patel KP; Vandermolen S; Herrey AS; Cheasty E; Menezes L; Moon JC; Pugliese F; Treibel TA
    Front Cardiovasc Med; 2022; 9():849540. PubMed ID: 35402562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESC Working Group on Valvular Heart Disease position paper--heart valve clinics: organization, structure, and experiences.
    Lancellotti P; Rosenhek R; Pibarot P; Iung B; Otto CM; Tornos P; Donal E; Prendergast B; Magne J; La Canna G; Piérard LA; Maurer G
    Eur Heart J; 2013 Jun; 34(21):1597-606. PubMed ID: 23293304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of valvular heart disease in patients with cancer: Multidisciplinary team, cancer-therapy related cardiotoxicity, diagnosis, transcatheter intervention, and cardiac surgery. Expert opinion of the Association on Valvular Heart Disease, Association of Cardiovascular Interventions, and Working Group on Cardiac Surgery of the Polish Cardiac Society.
    Płońska-Gościniak E; Piotrowski G; Wojakowski W; Gościniak P; Olszowska M; Lesiak M; Klotzka A; Grygier M; Deja M; Kasprzak JD; Kukulski T; Kosmala W; Suwalski P; Kolowca M; Widenka K; Hryniewiecki T
    Kardiol Pol; 2023; 81(1):82-101. PubMed ID: 36641646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of stress echocardiography for valvular heart disease.
    Kusunose K
    J Med Ultrason (2001); 2020 Jan; 47(1):81-89. PubMed ID: 31289972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the American College of Cardiology/American Heart Association and the European Society of Cardiology Guidelines for the Management of Patients With Valvular Heart Disease.
    Alame AJ; Karatasakis A; Karacsonyi J; Danek BA; Sorajja P; Gössl M; Garcia S; Jneid H; Kakouros N; Martinez-Parachini JR; Resendes E; Kalsaria P; Roesle M; Rangan BV; Banerjee S; Brilakis ES
    J Invasive Cardiol; 2017 Sep; 29(9):320-326. PubMed ID: 28420803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper.
    Lancellotti P; Pibarot P; Chambers J; La Canna G; Pepi M; Dulgheru R; Dweck M; Delgado V; Garbi M; Vannan MA; Montaigne D; Badano L; Maurovich-Horvat P; Pontone G; Vahanian A; Donal E; Cosyns B;
    Eur Heart J Cardiovasc Imaging; 2022 Apr; 23(5):e171-e232. PubMed ID: 35292799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive management of significant tricuspid regurgitation in clinical practice.
    Moral S; Abulí M; Méndez I; González-Gómez A; García-Quintana A; Menduiña I; Payá R; Esteban E; Sánchez PL; Díaz E; de la Morena G; Calvo-Iglesias F; Gallego P; Ballesteros E; Brugada R; Evangelista A
    Int J Cardiol; 2023 Mar; 375():66-73. PubMed ID: 36642332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional transesophageal echocardiography vs cardiac magnetic resonance in the assessment of planimetric mitral valve area in rheumatic mitral stenosis.
    Uygur B; Celik O; Ustabasioglu FE; Akinci O; Erturk M
    Echocardiography; 2018 Oct; 35(10):1621-1625. PubMed ID: 29981197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valvular Heart Disease in Patients with Chronic Kidney Disease.
    Kipourou K; O'Driscoll JM; Sharma R
    Eur Cardiol; 2022 Feb; 17():e02. PubMed ID: 35154392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey.
    Tribouilloy C; Bohbot Y; Kubala M; Ruschitzka F; Popescu B; Wendler O; Laroche C; Bartha E; Ince H; Simkova I; Vahanian A; Iung B
    Eur Heart J; 2022 Aug; 43(29):2756-2766. PubMed ID: 35511056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year epidemiological survey of valvular heart disease: changes in morbidity, etiological spectrum and management in a cardiovascular center of Southern China.
    Liu FZ; Xue YM; Liao HT; Zhan XZ; Guo HM; Huang HL; Fang XH; Wei W; Rao F; Deng H; Liu Y; Lin WD; Wu SL
    J Thorac Dis; 2014 Dec; 6(12):1724-30. PubMed ID: 25589965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging in valvular heart disease: clinical application and current role for patient management.
    Sommer G; Bremerich J; Lund G
    J Magn Reson Imaging; 2012 Jun; 35(6):1241-52. PubMed ID: 22588991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of Valvular Heart Disease in Heart Failure.
    Podlesnikar T; Delgado V; Bax JJ
    Card Fail Rev; 2018 Aug; 4(2):78-86. PubMed ID: 30206481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.